Transgenic mice comprising transcription control elements associated with mouse eosinophil peroxidase expression
US6858773B2 · kind B2 · utility
2Cited by
13References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 19, 2002 |
| Grant date | Feb 22, 2005 |
| Priority date | — |
| Expiry date | Apr 19, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2830/008
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to novel transcription control elements derived from a mouse eosinophil peroxidase gene. The novel transcription control elements described in the disclosure may comprise isolated polynucleotides, expression cassettes, vectors, recombinant cells, and transgenic animals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.